Published: Apr 2018
ACE Report #10244
Ace Report Cover Metabolic Disorders

Romosozumab versus placebo, alendronate, and teriparatide for postmenopausal osteoporosis

Study Type:Meta analysis
OE Level Evidence:2
Journal Level of Evidence:N/A

Romosozumab treatment in postmenopausal women with osteoporosis: a meta-analysis of randomized controlled trials

Climacteric. 2018 Apr;21(2):189-195

Contributing Authors: B Zhang W Zhang J Wu Y Cao S Zhang Y Liu Z Li Q Tang

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.


Please Login or Join to leave comments.